What question did this study set out to answer?

The study aims to evaluate the effectiveness of unmanipulated bone marrow infusion in treating RECQL4 −/− severe combined immunodeficiency (SCID).

March 8, 2026Open Access

Unmanipulated bone marrow infusion without conditioning can rescue RECQL4 −/− severe combined immunodeficiency

Key Points

The study aims to evaluate the effectiveness of unmanipulated bone marrow infusion in treating RECQL4 −/− severe combined immunodeficiency (SCID).
Evaluated the impact of unmanipulated bone marrow infusion
Assessed immune system recovery in subjects with RECQL4 mutations
Considered radiosensitivity effects on treatment options
Unmanipulated bone marrow infusion significantly improved immune function
Subjects demonstrated functional T cell activity after treatment
Treatment provided a viable alternative due to limited conditioning options

Abstract

Mutations in DNA helicase RECQL4 can cause immunodeficiency, including SCID. The T cell defects are intrinsic to the hematopoietic system and amenable to hematopoietic stem cell transplant. Radiosensitivity due to DNA-repair defects limits conditioning regimen options.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Grier et al. (Sat,) studied this question.

synapsesocial.com/papers/69ada885bc08abd80d5bb80c https://doi.org/https://doi.org/10.70962/jhi.20250169

Bookmark

View Full Paper